###### Strengths and limitations of this study

-   We constructed a series of multivariable hierarchical logistic regression models predicting outcomes and calculated the median OR to quantify the variation in patient outcomes at hospital level with adjusting for patient-level factors.

-   We observed substantial variations in patient outcomes, median differences of 34% in the odds of 1-month survival and 53% in the odds of favourable functional outcome at 1 month for any two otherwise similar patients who were treated by any two randomly selected hospitals.

-   The Japan Association for Acute Medicine OHCA Registry was combined with the All-Japan Utstein Registry. 10.9% of patients who were unable to be combined were excluded from the analysis as missing data, resulting in potential risk of selection bias.

Introduction {#s1}
============

Out-of-hospital cardiac arrest (OHCA) is one of the most important public health problems worldwide. Overall, 356 000 individuals in the USA and 127 000 in Japan annually develop OHCA with high mortality.[@R1] During the last decades, prior studies revealed factors that impact patient outcomes after OHCA, such as prehospital factors (quality of cardiopulmonary resuscitation (CPR) and early defibrillation),[@R3] patient factors (initial rhythm, age and origin of cardiac arrest)[@R7] and hospital factors (post-resuscitation care options, eg, targeted temperature management and early coronary angiography).[@R8] These findings enhanced resuscitation guidelines and survival after OHCA has been improving in some communities.[@R11]

Prior studies also showed that patient outcomes after OHCA significantly varied at multiple levels: between geographical regions,[@R13] emergency medical service (EMS) agencies[@R15] and receiving hospitals[@R16] in the USA, suggesting important disparities in healthcare provision. We recently reported substantial variation in functional outcome after OHCA in geographical regions in Japan between all 47 prefectures.[@R20] However, it remains unclear whether there is a variation in patient outcomes after OHCA between relevant units in the healthcare system, such as receiving hospitals. Detecting existing differences in health outcomes is the first step in the research of healthcare disparities, enabling to further understanding and reduction of the observed disparities.[@R21]

Our objective is to quantify the extent of between-hospital variation in survival and functional outcome after OHCA in Japan, accounting for patient demographics, cardiac arrest characteristics and prehospital interventions as well as clustering of patients within receiving hospitals.

Methods {#s2}
=======

Study design and setting {#s2-1}
------------------------

We performed a secondary analysis of the Japan Association for Acute Medicine OHCA Registry (JAAM-OHCA Registry). The methodology of the JAAM-OHCA Registry was previously reported elsewhere.[@R22] Briefly, the JAAM-OHCA Registry is a prospective multicentre OHCA registry with voluntary participation of 73 medical institutions in Japan. The registry included all patients with OHCA, defined as initiation of resuscitation attempts with shock delivery by an external defibrillator (by a layperson or EMS personnel) or chest compressions by EMS personnel, who were then transported to participating institutions between June 2014 and December 2015 (the most recent publicly available data at the time of the analysis). In Japan, all patients with OHCA who receive resuscitation by EMS personnel are transported to medical institutions regardless of the presence of return of spontaneous circulation (ROSC). The choice of transporting hospital is at the discretion of the EMS providers. The registry excluded OHCA patients who did not receive CPR at the participating institutions (ie, when resuscitative efforts were immediately terminated on hospital arrival), or for whom participation in the registry was refused either personally or by family members. OHCA patients who were transferred to the participating institutions from another hospital were also excluded. The registry is also combined with the All-Japan Utstein Registry of the Fire and Disaster Management Agency (FDMA), a prospective, nationwide, population-based registry of OHCA cases based on the Utstein style in Japan.

Receiving hospital setting {#s2-2}
--------------------------

The JAAM-OHCA Registry is a voluntary registry of participating hospitals with emergency departments, which includes critical care medical centres (CCMCs) certified by the Japanese Ministry of Health, Labour and Welfare that can accept emergency and severely ill patients transported by ambulance, including OHCA patients. To be licensed as a CCMC, a hospital should have ≥20 beds and an intensive care unit and be able to provide highly specialised treatments such as extracorporeal resuscitation, targeted temperature management and percutaneous coronary intervention (PCI), 24 hours a day. CCMCs as well as non-CCMCs with an emergency care department can participate in this registry. The number of institutions participating to the JAAM-OHCA Registry was 73 in 2015.[@R22]

Study population {#s2-3}
----------------

We included adults (≥18 years old) with EMS-treated OHCA of medical origin who were registered with the JAAM-OHCA Registry.[@R23] We excluded patients with missing data for important patient-level covariates, patients whose initial rhythm code was 'others', patients with OHCA of non-medical origin (trauma, toxicity, drowning, traffic injury, hypothermia, anaphylaxis and others), and patients treated by hospitals that treated 10 or fewer OHCA cases annually in this dataset.[@R15]

Study variables {#s2-4}
---------------

Study variables included in risk-adjusted models were (1) patient demographics: age (continuous) and sex (male or female); (2) cardiac arrest event characteristics: cause of arrest (cardiac, non-cardiac), initial rhythm (ventricular fibrillation (VF)/ventricular tachycardia (VT) or pulseless electrical activity (PEA)/asystole), witnessed collapse (none, a bystander or EMS personnel); (3) layperson interventions: bystander CPR (presence or absence), dispatcher CPR instruction (presence or absence) and shock delivery with public automated external defibrillator (AED) (presence or absence); (4) EMS interventions: prehospital defibrillation (presence or absence), prehospital advanced airway placement with tracheal intubation or supraglottic airway device (yes or no), and prehospital epinephrine administration (presence or absence); (5) EMS time variables: the interval from the first telephone call to CPR initiation by EMS providers and from CPR initiation by EMS providers to hospital arrival (measured as continuous variables). These covariates were chosen a priori based on their known associations with survival from prior studies of OHCA, biologic plausibility and adequate ascertainment.[@R3]

Outcome measure {#s2-5}
---------------

The primary outcome was 1-month survival after OHCA. The secondary outcome was functional status at 1 month after OHCA occurrence using the Glasgow-Pittsburgh cerebral performance category (CPC) scale (category 1, good cerebral performance; 2, moderate cerebral disability; 3, severe cerebral disability; 4, coma or vegetative state; 5, death/brain death). Favourable functional outcome was defined as a CPC of 1 or 2.[@R24]

Statistical analysis {#s2-6}
--------------------

We first described the unadjusted rate of 1-month survival after OHCA within each hospital. We ranked and grouped hospitals into quartiles according to their unadjusted survival rates and reported differences in patient-level characteristics by quartiles. We described the variability in unadjusted 1-month survival and favourable functional outcome between receiving hospitals.

We then constructed a series of multivariable hierarchical logistic regression models to predict 1-month survival and favourable functional outcome, based on previously described variables. These models accounted for potential confounders and clustering of patients within each hospital. We treated hospitals as a random effect and nested individual patients within each hospital, whereas patient-level variables were modelled as fixed effects. From these models, we calculated adjusted 1-month survival and favourable functional outcome for each hospital and ranked hospitals for each outcome. We also calculated median ORs (MORs) and 95% CI to quantify the between-hospital variation in outcomes.[@R26] We derived MORs from the variance estimate of the random intercept in the hierarchical regression models by Bayesian method.[@R26] Conceptually, the MORs represent the relative odds of outcome for two patients with similar characteristics between two different, randomly selected hospitals.[@R26] For example, an MOR of 2.0 indicates a median twofold difference in the odds of outcome for similar individuals treated by two different, randomly selected hospitals. Subgroup analyses of 1-month survival and favourable functional outcome were conducted to confirm the consistency of between-hospital variation within each subgroup. Subgroups were defined by initial rhythm: those with a shockable rhythm (VF, VT and shocked by an AED) versus non-shockable rhythm (PEA, asystole and not shocked by an AED); witnessed collapse: witnessed (a bystander or EMS personnel) versus non-witnessed; the presence of ROSC prior to hospital arrival (field ROSC): field ROSC versus non-field ROSC. Field ROSC was defined as palpable pulse prior to hospital arrival at least once.

We used R V.3.2.4 (The R Foundation for Statistical Computing, Vienna, Austria) and Stata V.12 (StataCorp, College Station, Texas, USA) for our analyses.

Patient and public involvement {#s2-7}
------------------------------

In this study, patients and public were not involved. We performed a secondary analysis of the data of the JAAM-OHCA Registry as described above.

Results {#s3}
=======

The patient flow diagram is seen in [figure 1](#F1){ref-type="fig"}. From June 2014 to December 2015, 13 469 patients with EMS-treated OHCA were registered with the JAAM Registry. Of these, 9303 patients with EMS-treated OHCA of medical origin who were treated at 67 hospitals were eligible for our analyses after excluding 3850 patients who met exclusion criteria. Patients with missing data included 1467 patients who were not included in the Utstein data of FDMA and 14 patients in whom prehospital epinephrine administration was unknown. The prevalence of ROSC after OHCA was 12.2% (1137/9303), 1-month survival after OHCA was 7.1% (663/9303), and favourable functional outcome was 3.6% (331/9303).

![Flow diagram for patient selection. OHCA, out-of-hospital cardiac arrest; EMS, emergency medical service; JAAM, Japan Association for Acute Medicine; ROSC, return of spontaneous circulation.](bmjopen-2019-033919f01){#F1}

Patient demographics are summarised in [table 1](#T1){ref-type="table"}. When categorising hospitals into quartiles based on the rate of patient survival, patients treated by the highest quartile hospitals, compared with those at the lowest quartile hospitals, tended to be younger. In cardiac arrest event characteristics, cardiac cause, non-shockable initial rhythms (PEA/asystole) and unwitnessed arrest were observed less frequently in the patients treated by the highest quartile hospitals, compared with that in the patients treated by the lowest quartile hospitals. For layperson interventions, patients treated by the highest quartile hospitals, compared with those at the lowest quartile hospitals, tended to receive bystander CPR, dispatcher CPR instruction and shock delivery with public-access AEDs more often. For EMS interventions, patients treated by the highest quartile hospitals, compared with those at the lowest quartile hospitals, tended to receive defibrillation by EMS providers, advanced airway management and epinephrine administration more often.

###### 

Patient demographic data and characteristics

  Characteristic                                         Total                  N (%)                                                                                       
  ------------------------------------------------------ ---------------------- ---------------------- ---------------------- ---------------------- ---------------------- --------
  **No of** **p** **atients**                            9303                   1481                   3106                   2773                   1943                   
  **No of** **h** **ospital** **s**                      67                     17                     17                     17                     16                     
  **Patient** **demographics**                                                                                                                                              
   Age (median (IQR))                                    76.00 (65.00--85.00)   79.00 (66.00--86.00)   78.00 (66.00--85.00)   76.00 (64.00--84.00)   73.00 (62.00--82.00)   \<0.01
   Female                                                3696 (39.7)            570 (38.5)             1256 (40.4)            1146 (41.3)            724 (37.3)             \<0.05
  **Cardiac arrest event**                                                                                                                                                  
   Cardiac cause (Utstein)                               2412 (25.9)            402 (27.1)             741 (23.9)             820 (29.6)             449 (23.1)             \<0.01
   Cardiac cause (JAAM)                                  3725 (40.0)            574 (38.8)             1222 (39.3)            1182 (42.6)            747 (38.4)             \<0.05
   Initial rhythm                                                                                                                                                           \<0.01
   VF/VT                                                 1036 (11.1)            112 (7.6)              291 (9.7)              289 (10.4)             344 (17.7)             
   PEA/asystole                                          8267 (88.9)            1369 (92.4)            2815 (90.6)            2484 (89.6)            1599 (82.3)            
   **Witnessed collapse**                                                                                                                                                   \<0.01
   None                                                  4954 (53.3)            827 (55.8)             1716 (55.2)            1577 (56.9)            834 (42.9)             
   Bystander                                             3759 (40.4)            550 (37.1)             1209 (38.9)            1042 (37.6)            958 (49.3)             
   EMS                                                   590 (6.3)              104 (7.0)              181 (5.8)              154 (5.6)              151 (7.8)              
  **Layperson interventions**                                                                                                                                               
   Bystander CPR                                         4285 (46.1)            672 (45.4)             1428 (46.0)            1291 (46.6)            894 (46.0)             0.90
   Dispatcher CPR instruction                            4863 (52.3)            815 (55.0)             1630 (52.5)            1347 (48.6)            1071 (55.1)            \<0.01
   Shock delivery with AED                               133 (1.4)              19 (1.3)               52 (1.7)               28 (1.0)               34 (1.7)               0.09
  **EMS interventions**                                                                                                                                                     
   Defibrillation                                        1405 (15.1)            175 (11.8)             413 (13.3)             386 (13.9)             431 (22.2)             \<0.01
   Advanced airway management                            5247 (56.4)            736 (49.7)             1744 (56.1)            1716 (61.9)            1051 (54.1)            \<0.01
   Epinephrine administration                            2624 (28.2)            333 (22.5)             934 (30.1)             835 (30.1)             522 (26.9)             \<0.01
  **Time intervals (median** **(** **IQR** **)** **)**                                                                                                                      
   From first telephone call to CPR                      9.00 (7.00--11.00)     9.00 (7.00--11.00)     9.00 (7.00--11.00)     9.00 (7.00--11.00)     8.00 (7.00--11.00)     \<0.01
   From CPR to hospital arrival                          23.00 (18.00--30.00)   24.00 (18.00--30.00)   24.00 (18.00--30.00)   23.00 (18.00--29.00)   23.00 (18.00--29.00)   \<0.01
  **Outcomes**                                                                                                                                                              
   ROSC                                                  1137 (12.2)            126 (8.5)              303 (9.8)              349 (12.6)             359 (18.5)             \<0.01
   1-month survival                                      663 (7.1)              30 (2.0)               138 (4.4)              221 (8.0)              274 (14.1)             \<0.01
   Favourable functional outcome                         331 (3.6)              20 (1.4)               50 (1.6)               107 (3.9)              154 (7.9)              \<0.01

AED, automated external defibrillator; CPR, cardiopulmonary resuscitation; EMS, emergency medical service; JAAM, Japan Association for Acute Medicine; PEA, pulseless electrical activity; ROSC, return of spontaneous circulation; VF, ventricular fibrillation, VT, ventricular tachycardia.

After calculating adjusted 1-month survival and favourable functional outcome for each hospital, we ranked hospitals and constructed a caterpillar plot ([figure 2](#F2){ref-type="fig"}). The adjusted rate of 1-month survival after OHCA in each hospital ranged from 1.6% to 13.8% ([figure 2A](#F2){ref-type="fig"}). The adjusted rate of favourable functional outcome ranged from 0.7% to 7.3% ([figure 2B](#F2){ref-type="fig"}).

![Caterpillar plot for adjusted rate of 1-month survival (A) and favourable functional outcome (B) among OHCA patients within each hospital. Adjusted for age, sex, cause of arrest (cardiac or non-cardiac), initial rhythm (VF/VT or PEA/asystole), witnessed collapse (none, a bystander or EMS personnel), bystander CPR (presence or absence), dispatcher CPR instruction (presence or absence), shock delivery with public AED (presence or absence), prehospital defibrillation (presence or absence), prehospital advanced airway placement with tracheal intubation or supraglottic airway device (yes or no), prehospital epinephrine administration (presence or absence), the interval from the first telephone call to CPR initiation by EMS providers and that from CPR initiation by EMS providers to hospital arrival. AED, automated external defibrillator; CPR, cardiopulmonary resuscitation; EMS, emergency medical service; OHCA, out-of-hospital cardiac arrest; PEA, pulseless electrical activity; VF, ventricular fibrillation, VT, ventricular tachycardia.](bmjopen-2019-033919f02){#F2}

The primary and secondary outcomes are shown in [table 2](#T2){ref-type="table"}. The unadjusted MOR for 1-month survival after OHCA was 1.49 (95% CI 1.26 to 1.91). After adjustment for patient-level factors, the MOR for 1-month survival after OHCA slightly decreased to 1.34 (95% CI 1.16 to 1.67). The unadjusted MOR for favourable functional outcome was 1.91 (95% CI 1.40 to 3.00). After adjustment for patient-level factors, the MOR for favourable functional outcome slightly decreased to 1.53 (95% CI 1.20 to 2.24).

###### 

Between-hospital variation in 1-month survival and favourable functional outcome after OHCA

                                         Median OR (95% CI)
  -------------------------------------- ---------------------
  **1** **-** **month** **survival**     
   Unadjusted                            1.49 (1.26 to 1.91)
   Adjusted for select variables**\***   1.34 (1.16 to 1.67)
  **Favourable functional outcome**      
   Unadjusted                            1.91 (1.40 to 3.00)
   Adjusted for select variables**\***   1.53 (1.20 to 2.24)

\*Adjusted for age, sex, cause of arrest (cardiac or non-cardiac), initial rhythm (VF/VT or PEA/asystole), witnessed collapse (none, a bystander or EMS personnel), bystander CPR (presence or absence), dispatcher CPR instruction (presence or absence), shock delivery with public AED (presence or absence), prehospital defibrillation (presence or absence), prehospital advanced airway placement with tracheal intubation or supraglottic airway device (yes or no), prehospital epinephrine administration (presence or absence), the interval from the first telephone call to CPR initiation by EMS providers and that from CPR initiation by EMS providers to hospital arrival.

AED, automated external defibrillator; CPR, cardiopulmonary resuscitation; EMS, emergency medical service; OHCA, out-of-hospital cardiac arrest; PEA, pulseless electrical activity; VF, ventricular fibrillation; VT, ventricular tachycardia.

The adjusted MORs for survival and functional outcome among the subgroups stratified by initial rhythm, witnessed collapse and the presence of ROSC prior to the hospital arrival are seen in [table 3](#T3){ref-type="table"}.

###### 

Adjusted median ORs for 1-month survival and favourable functional outcome of OHCA patients stratified according to pre-specified subgroups

                                                       Adjusted median OR\* (95% CI)   
  ---------------------------------------------------- ------------------------------- ---------------------
  **Initial rhythm**                                                                   
   Shockable                                           1.47 (1.19 to 2.03)             1.55 (1.14 to 2.53)
   Non-shockable                                       1.32 (1.09 to 1.81)             1.32 (1.02 to 2.19)
  **Witnessed collapse**                                                               
   Witnessed                                           1.39 (1.16 to 1.82)             1.67 (1.25 to 2.69)
   Non-witnessed                                       1.22 (1.00 to 1.87)             1.18 (1.00 to 2.29)
  **Presence of ROSC prior to the hospital arrival**                                   
   Field ROSC                                          1.12 (1.01 to 1.40)             1.35 (1.02 to 2.22)
   Non-field ROSC                                      1.35 (1.08 to 1.90)             1.12 (1.00 to 1.62)

\*Adjusted for age, sex, cause of arrest (cardiac or non-cardiac), initial rhythm (VF/VT or PEA/asystole), witnessed collapse (none, a bystander or EMS personnel), bystander CPR (presence or absence), dispatcher CPR instruction (presence or absence), shock delivery with public AED (presence or absence), prehospital defibrillation (presence or absence), prehospital advanced airway placement with tracheal intubation or supraglottic airway device (yes or no), prehospital epinephrine administration (presence or absence), the interval from the first telephone call to CPR initiation by EMS providers and that from CPR initiation by EMS providers to hospital arrival.

AED, automated external defibrillator; CPR, cardiopulmonary resuscitation; OHCA, out-of-hospital cardiac arrest; PEA, pulseless electrical activity; ROSC, return of spontaneous circulation; VF, ventricular fibrillation; VT, ventricular tachycardia.

Discussion {#s4}
==========

In this analysis of a large prospective registry of OHCA in Japan, we found substantial differences in 1-month survival and favourable functional outcome between the 67 receiving hospitals. These differences persisted after adjustment for known patient and prehospital factors. We observed median differences of 34% in the odds of survival and 53% in the odds of favourable functional outcome at 1 month for any two otherwise similar patients who were treated by any two randomly selected hospitals. Our data suggest that the between-hospital variation resulted from unadjusted patient, EMS, hospital and/or community characteristics.

Prior studies reported that factors at multiple levels (eg, patient, EMS, hospital and geographical region level) were associated with patient outcomes after OHCA.[@R3] Mumma *et al* reported significant variation in good neurological recovery following OHCA between 128 hospitals where PCI is available 24 hours/7 days in California, USA. Multivariable hierarchical logistic regression models were constructed (adjusted rates of good neurological recovery, 18% to 39%; p\<0.001).[@R28] Our present study corroborated this prior study and confirmed the between-hospital variation in survival and functional outcome after OHCA in different healthcare settings. The between-hospital variation might result from the hospital characteristics that prior studies reported, such as OHCA case volume,[@R17] and cath-lab availability (24/7 PCI or limited PCI capability).[@R30] However, in Mumma's study, the between-hospital variation in good neurological recovery following OHCA existed even though hospitals with similar characteristics (24/7 PCI centre) were incorporated.[@R28] These results suggest that there were unmeasured hospital characteristics causing the between-hospital variation. On the other hand, Nallamothu *et al* evaluated resuscitation teams at hospitals with high in-hospital cardiac arrest survival with a qualitative study and discovered four broad themes that distinguish top-performing hospitals: team design, team composition and roles, communication and leadership, and training and educational efforts.[@R33] This may suggest that resuscitation team characteristics and organisation, both prehospital and in-hospital, contribute to the variation in patient outcomes after OHCA. Further research is needed to identify characteristics of high-performing hospitals in OHCA and should be targeted in future interventions to improve care after OHCA.

In our subgroup analyses, there were significant between-hospital variations among all subgroups in 1-month survival and favourable functional outcome. We observed larger between-hospital variations in survival and favourable functional outcome among shockable and witnessed groups, compared with non-shockable and unwitnessed groups. This might suggest that hospital factors such as post-resuscitation care at hospital level (eg, PCI and targeted temperature management) are determinants of patient outcomes among patients with favourable features. On the other hand, those without field ROSC had a larger variation in survival, compared with those with field ROSC. This suggests that performance of CPR after hospital arrival contributed to survival in those without field ROSC.

Our study has several limitations. First, we cannot determine which unmeasured factors explain the observed differences in outcomes. These unmeasured factors include patient comorbidity,[@R34] experience and training of treating EMS personnel,[@R3] post-resuscitation practice[@R8] and neighbourhood factors.[@R35] Second, our inference may not be fully generalisable to other healthcare settings. There are 288 tertiary hospitals to which OHCA patients are transported in Japan and 73 hospitals were registered in this dataset.[@R22] There may be selection bias due to the characteristics of the registered hospitals, for example, hospitals in the registry may have emergency departments with higher motivation for resuscitation. Third, the JAAM-OHCA registry excluded cases wherein resuscitative efforts were immediately terminated on hospital arrival. The decision to terminate resuscitation could have varied between hospitals, potentially leading to selection bias. However, in subgroup analyses, we observed persisting large variation in outcomes among those with known favourable features such as shockable initial rhythm, witnessed arrest and field ROSC, supporting the robustness of our findings, because those with favourable features would have been less likely to impact selection bias. Fourth, as the data collection period was between 2014 and 2015, our results may not reflect current variation in patient outcomes. Lastly, there are 1467 patients (10.9% of all registered patients) who could not be combined with the data of All-Japan Utstein Registry. We excluded these patients from the analysis as missing data, resulting in a risk of selection bias.

Conclusions {#s5}
===========

In this secondary analysis of a large prospective OHCA registry in Japan, patient outcomes after OHCA varied substantially between hospitals, despite adjustment for known factors associated with different outcomes. Further research is required to identify modifiable factors that contribute to this observed variation to improve patient outcomes after OHCA.
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